SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-013627
Filing Date
2022-04-06
Accepted
2022-04-06 06:39:56
Documents
4
Period of Report
2022-04-06

Document Format Files

Seq Description Document Type Size
1 6-K orph-6k_20220406.htm 6-K 31905
2 EX-99.1 orph-ex991_6.htm EX-99.1 15167
3 GRAPHIC gzysa2r1co1i000001.jpg GRAPHIC 5361
4 GRAPHIC gzysa2r1co1i000002.jpg GRAPHIC 5361
  Complete submission text file 0001564590-22-013627.txt   63112
Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Filer) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39545 | Film No.: 22809338
SIC: 2834 Pharmaceutical Preparations